Form 4: Eton Pharmaceuticals Insider Sells Shares
Insider Transaction (Form 4)
Opaleye Management Inc. reported changes in beneficial ownership of Eton Pharmaceuticals, Inc. common stock on July 14, 2026.
Summary
- Open-market sale: disposed of 15,000 Common Stock, par value $0.001 per share at $37.54 ($563,146) on July 14, 2026; holds 2,665,000 after (Indirect).
- Open-market sale: disposed of 13,315 Common Stock, par value $0.001 per share at $37.54 ($499,886) on July 14, 2026; holds 40,000 after (Indirect).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,063,033 of stock on the open market.
Insider Transactions
Opaleye Management Inc. — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-14 | Open-market sale | Common Stock, par value $0.001 per share | 15,000 | $38 | $563.1K | 2,665,000 |
| 2026-07-14 | Open-market sale | Common Stock, par value $0.001 per share | 13,315 | $38 | $499.9K | 40,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-14 | Open-market sale (15,000 shares) |
| 2026-07-14 | Open-market sale (13,315 shares) |
Keywords
insider transaction, Form 4, ETON, Eton Pharmaceuticals, Inc., bearish, Opaleye Management Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.